Valproic Acid: A New Candidate of Therapeutic Application for the Acute Central Nervous System Injuries

被引:57
作者
Chen, Sheng [1 ]
Wu, Haijian [1 ]
Klebe, Damon [2 ,3 ]
Hong, Yuan [1 ]
Zhang, Jianmin [1 ]
机构
[1] Zhejiang Univ, Sch Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China
[2] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Dept Pharmacol, Loma Linda, CA 92350 USA
基金
中国国家自然科学基金;
关键词
Valproic acid; Brain injuries; Histone deacetylases inhibitor; Neuroprotection; HISTONE DEACETYLASE INHIBITORS; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; FOCAL CEREBRAL-ISCHEMIA; PROTECTS DOPAMINERGIC-NEURONS; PROMOTES FUNCTIONAL RECOVERY; MOOD STABILIZER; MEDIATED NEUROPROTECTION; BARRIER DISRUPTION; HEMORRHAGIC-SHOCK;
D O I
10.1007/s11064-014-1241-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute central nervous system (CNS) injuries, including stroke, traumatic brain injury (TBI), and spinal cord injury (SCI), are common causes of human disabilities and deaths, but the pathophysiology of these diseases is not fully elucidated and, thus, effective pharmacotherapies are still lacking. Valproic acid (VPA), an inhibitor of histone deacetylation, is mainly used to treat epilepsy and bipolar disorder with few complications. Recently, the neuroprotective effects of VPA have been demonstrated in several models of acute CNS injuries, such as stroke, TBI, and SCI. VPA protects the brain from injury progression via anti-inflammatory, anti-apoptotic, and neurotrophic effects. In this review, we focus on the emerging neuroprotective properties of VPA and explore the underlying mechanisms. In particular, we discuss several potential related factors in VPA research and present the opportunity to administer VPA as a novel neuropective agent.
引用
收藏
页码:1621 / 1633
页数:13
相关论文
共 106 条
[1]  
Abdanipour Alireza, 2012, Iranian Biomedical Journal, V16, P90, DOI 10.6091/ibj.1060.2012
[2]   A global perspective on spinal cord injury epidemiology [J].
Ackery, A ;
Tator, C ;
Krassioukov, A .
JOURNAL OF NEUROTRAUMA, 2004, 21 (10) :1355-1370
[3]   Inflammation After Stroke: Mechanisms and Therapeutic Approaches [J].
Ahmad, Muzamil ;
Graham, Steven H. .
TRANSLATIONAL STROKE RESEARCH, 2010, 1 (02) :74-84
[4]   GDNF, NGF and BDNF as therapeutic options for neurodegeneration [J].
Allen, Shelley J. ;
Watson, Judy J. ;
Shoemark, Deborah K. ;
Barua, Neil U. ;
Patel, Nikunj K. .
PHARMACOLOGY & THERAPEUTICS, 2013, 138 (02) :155-175
[5]  
Ambrozaitis Kazys Vytautas, 2006, Medicina (Kaunas), V42, P255
[6]   Expression of Histone Deacetylases in Cellular Compartments of the Mouse Brain and the Effects of Ischemia [J].
Baltan, Selva ;
Bachleda, Amelia ;
Morrison, Richard S. ;
Murphy, Sean P. .
TRANSLATIONAL STROKE RESEARCH, 2011, 2 (03) :411-423
[7]   Regulation of chromatin by histone modifications [J].
Bannister, Andrew J. ;
Kouzarides, Tony .
CELL RESEARCH, 2011, 21 (03) :381-395
[8]   Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression [J].
Bauernfeind, Franz G. ;
Horvath, Gabor ;
Stutz, Andrea ;
Alnemri, Emad S. ;
MacDonald, Kelly ;
Speert, David ;
Fernandes-Alnemri, Teresa ;
Wu, Jianghong ;
Monks, Brian G. ;
Fitzgerald, Katherine A. ;
Hornung, Veit ;
Latz, Eicke .
JOURNAL OF IMMUNOLOGY, 2009, 183 (02) :787-791
[9]   Valproic Acid-Mediated Neuroprotection and Regeneration in Injured Retinal Ganglion Cells [J].
Biermann, Julia ;
Grieshaber, Philippe ;
Goebel, Ulrich ;
Martin, Gottfried ;
Thanos, Solon ;
Di Giovanni, Simone ;
Lagreze, Wolf Alexander .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (01) :526-534
[10]   Anticancer activities of histone deacetylase inhibitors [J].
Bolden, Jessica E. ;
Peart, Melissa J. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :769-784